Ken Griffin's position in Iovance Biotherapeutics is currently worth $3.99 Million. That's 0.00% of their equity portfolio (1663rd largest holding). The first Iovance Biotherapeutics trade was made in Q3 2017. Since then Ken Griffin bought shares 37 more times and sold shares on 36 occasions. The investor's estimated purchase price is $5.9 Million, resulting in a loss of 32%.